Prothena Corp Public (PRTA) Non-Current Deferred Tax Liability (2013)
Prothena Corp Public (PRTA) posted quarterly Non-Current Deferred Tax Liability of $201000.0 for Q2 2013.
Powered by 
Analysis
Prothena Corp Public (PRTA) Non-Current Deferred Tax Liability (2013) Analysis & Trends
Prothena Corp Public's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $201000.0 for Q2 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Prothena Corp Public | 507.63 Mn | 219.43 Mn | - |